October 10, 2017 / by Akib Uddin
The incredible pace at which mHealth and software moves requires regulatory bodies to think of new approaches to ensure people get access to products in a timely manner.
The FDA been working towards developing new approaches to evaluating mHealth apps to accelerate the review process. In July the FDA announced their Pre-Certification for Software Pilot Program. Recently, they have chosen the first nine companies that are part of the initial pilot program. Of these, 7 have ties to diabetes!
You can find more information here.